Is Viking Therapeutics (VKTX) Still Attractive After Recent Share Price Swings?
- Wondering if Viking Therapeutics at around US$33 is still offering value or if most of the story is already priced in? This article focuses squarely on what the numbers say about its valuation.
- The stock has seen a mix of shorter term weakness and longer term strength, with a 7.2% decline over the past week, a 1.4% gain over the last 30 days, a 6.9% decline year to date, and a 27.2% return over the past year.
- Recent attention on Viking Therapeutics has been shaped by ongoing developments around its drug pipeline, regulatory progress, and partnerships, which tend to influence how investors think about future cash flows and risk. These kinds of updates often help explain why returns can differ over short and long timeframes.
- Viking…
Source link
